Abstract -The accurate determination of molybdenum in biological materials is of considerable importance because of the essential role played by this element in human metabolism. However, data on the Mo content in biological samples and especially in clinical materials are often contradictory due to the inadequate sensitivity and reliability of the instrumental techniques used and to insufficient control of contamination during the analytical procedure. Despite recent developments in Mo determination by electrothermal atomic absorption and plasma atomic emission spectrometry, measurements in human blood and serum remain beyond the scope of most hospital laboratories involved in the usual routine testing. Further development of atomic spectrometric methods or a wider availability of neutron activation analysis may provide more data which is required for a better understanding of the nutritional role of Mo and its metabolism in humans. Advantages and limitations of the analytical techniques used for the determination of Mo in biological materials are critically discussed with particular attention given to clinical samples. The most common sources of analytical error are discussed and methods for their reduction are given.
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BIOCHEMICAL A N D CLINICAL BACKGROUND
As early as 1953 (ref. 1) molybdenum was recognized to be an essential trace element for many species including man. It is a component of many enzymes responsible for the initial stages of nitrogen, carbon and sulfur metabolism of plants, animals and man and participates in a large number of enzymatic reactions (ref.
2,3).
There is an absolute dependence by plants on Mo as it plays a vital role in the earth nitrogen cycle where it is involved both in nitrate reduction and nitrogen fixation.
Although molybdenum is essential for animals it shows evidence of toxicity at high levels. General symptoms of excess doses of Mo for ruminants are: retarded growth, decreased milk and meat production, osteoporosis, severe gastroenteritis and coma (ref. Molybdenum intoxication depends on its speciation and is also influenced by the uptake of other elements such as S"' , W"', Cu, Pb and Zn.
In humans, a deficiency of Mo in the diet may lead to some healths deffects. Diets with a low Mo content (20 pg/kg) adversely effect growth and may lead to neurogical disorders and even early death (ref. 6). Molybdenum also seems to play a positive role in the prevention of tooth decay (ref. 7). On the other hand, excess doses of Mo can be detrimental, persons having a diet rich in Mo being susceptible to gout, uricemia and xanthinuria and often suffer from an inflammation of extremities due to excess uric acid deposition (ref. 8, 9) .
The practice of supplementing human diets with trace elements has stimulated studies of Mo as an essential nutrient. Several studies using diets providing between 1 and 14 pg of Mo per kg body weight per day report that an optimal diet should provide about 2 pg Mo per kg body weight per day (ref. 7) . This result is comparable with a daily intake of 128 pg Mo proposed recently for a mixed diet composite (USDIET-I) (ref. 10). The Mo requirement for infants is closely reflected in the Mo content of breast milk (5-63 ndg) with the level depending on the time after parturition (ref. [11] [12] [13] [14] .
It must be emphasized that studies of Mo metabolism in man have often be hampered by the lack of sufficiently sensitive analytical methods for monitoring Mo in human tissues and body fluids. For this reason in many cases it is difficult to determine whether the symptoms attributed to Mo defficiency or excess are due to biological variations or simply to experimental error. A better understanding of the role of Mo in human nutrition depends on improving the sensitivity and accuracy of the analytical methods involved. Only then will the biological function of Mo and the role of Mo as an essential trace nutrient be fully understood.
MOLYBDENUM CONCENTRATIONS OF INTEREST
The level of Mo in plants depends on the soil content and soil conditions (ref. Many biochemical laboratories can now determine Mo at the above levels owing to an increased use of electrothermal atomic absorption and inductively coupled plasma emission spectrometry. However difficulties arise in the determination of Mo at the sub-ng level. They are best illustrated by the disparate values for Mo content in human serum and whole blood obtained by different workers. The results reported vary by about two orders of magnitude (from 0.55 to 257 ng/ml for serum (ref. [31] [32] [33] and from 0.6 to 13.1 ng/ml for the whole blood (ref. 25, [34] [35] [36] ). Certain environmental and individual differences may of course exist, but such large discrepancies are more likely to be caused by the use of analytical techniques of insufficient accuracy as well as by contamination factors. The more probable values seem to be the lower ones obtained by Versieck et al. (ref. 31, 33) and confirmed by other investigators (ref. [37] [38] [39] . These workers were quite aware of the risk of contamination and introduced quality control into their procedures. However, it is possible, that the serum Mo content is even lower and the present level is dictated by the limitations of curren! analytical technology. The establishment of the true serum Mo level is also hampered by the lack of suitable reference materials. Until a human serum Certified Reference Material is available for Mo, workers are advised to institute rigorous quality control procedure and be cautious with any data not consistent with the currently accepted level i.e. 0.5-0.6 ng/ml (ref. 31, 33, 37) .
SAMPLE HANDLING PRIOR TO MEASUREMENT
Although Mo is not a common element in the environment contamination represents a great hazard, when analysing samples where Mo is present at ng/g (human milk and tissues) or sub-ng/ml (human blood and serum) levels. Particularly at the sub-ng/g level contamination is likely to eclipse the original Mo content in the sample (ref. 32) and this is the main reason for large discrepancies in the results obtained. Since many errors arise at an early stage of the analytical procedure (sample collection and storage), information on the history of the sample must be available to the analyst.
One of the sources of contamination is the use of Mo-containing stainless steel needles, scalpels, scissors and other surgical tools for sampling. The Mo release from these instruments was reported (ref. 25) to be lower than 1 ng but this is nevertheless too great at sub-ng/g levels. Recently, Mianzhi and Barnes (ref, 40) , analyzing commercial serum, found a Mo content of 20.7k2.6 ngfml, much higher than the currently accepted value, probably because of contamination during sampling. Pietra et al. (ref. 25) found it impossible to estimate the Mo contamination in the blood collection process and their values of 8.1 ng/ml and 11.3 ngfml are much higher than currently accepted ones (ref. 34, 36) . For these reasons needles made of Pt-Ir, Pt-Ru (ref. 41) , siliconized metal needles, titanium surgical tools as well as plastic catheters and cannula (ref. 42) are recommended and to avoid contamination the first portion of the sample should be discarded (ref. (ref. [31] [32] [33] for blood collection were cleaned with twice distilled water, boiled in a mixture of equal volumes of nitric acid (min. 65%) and sulfuric acid (96%) (Suprapure; Merck), rinsed again and finally steam cleaned with triple quartz distilled water. Clean room conditions are usually not necessary for Mo determination but the analyst should be aware that considerable airborne contamination may arise when samples are taken in places of high Mo exposure.
The procedures for the determination of Mo usually involve sample drying, digestion and/or a separation step. The analyst should always bear in mind that all manipulations at the sample preparation stage may result either in contamination and/or the loss of the analyte. Freeze drying (8 h ) for reagent and sample preparation were cleaned by soaking for at least 2 h in a solution of NRS-250 detergent, rinsing with distilled water and soaking again for at least 2 h in a polyethylene bin containing a 10% v/v solution of reagent grade nitric acid in distilled water. Then they were thoroughly rinsed with demineralized distilled water (DDW), dried face down on rubber mating and stored in plastic bags. A final DDW rinse was performed immediately before use. The Teflon digestion vessels were cleaned by refluxing for at least 1 h with 1 ml of concd. Ultrex nitric acid, followed by a thorough DDW rinse. The Teflon caps for the vessels were cleaned by soaking overnight in a 10% v/v solution of Ultrex nitric acid in DDW and thoroughly rinsed with DDW.
The whole procedure for sample preFaration and Mo preconcentration should always be carefully evaluated with respect to various sources of contamination such as reagents, glassware used and airborne particles and it is mandatory to include blank experiments in parallel.
ANALYTICAL TECHNIQUES FOR M o DETERMINATION: GENERAL
As for all analyses, the determination of Mo in biological materials should be subject to careful statistical evaluation (ref. 46, 47) . Wherever possible Mo should be determined in duplicate by at least two independent analytical techniques. Analysts should use Certified Reference Materials (CRMs) for procedure validation (ref. 48) . However, in the case of Mo serious difficulties arise as the most suitable method for its determination at the sub-ng/g levels is neutron activation analysis (ref. 49) which is still inaccessible to many laboratories and also the number of biological CRMs with a certified Mo content remains small (ref. 42) . Moreover, most of these materials have a certified Mo content at the pg/g level, relevant to the analysis of plants: NBS SRM 1571 orchard leaves (0.3 pg/g), NBS SRM 1572 citrus leaves (0.17 pg/g), Bowen's kale (2.3 pg/g) or animal tissue: NBS SRM 1577a bovine liver (3.5 pg/g). To date, there is no CRM available for Mo in human serum or blood. The recently introduced NBS SRM 8419 bovine serum (12 ng/ml) has only partially filled the lack of a CRM for this matrix as the Mo concentration in human serum is an order of magnitude lower that in animal serum. At present, trace elements (including Mo) are being determined in the new NBS SRM 909 human serum (ref. 38) but until it appears on the market, workers determining the Mo content in human blood and serum must institute a rigorous regime of analytical quality control and check that they are consistent with currently accepted Mo levels in human body fluids.
General criteria for the selection of a method suitable for trace analysis are: sensitivity, accuracy, precision, speed, minimum sample pretreatment as well as cost and availability. Many analytical methods meet relevant criteria for the determination of Mo at the pg/g level in plants, most tissue samples and foodstuffs. They include a variety of techniques such as spectrophotometry, polarography, voltammetry, emission spectrography, X-ray fluorescence as well as flame atomic absorption spectrometry but they usually require a Mo separation and preconcentration step. The most widely used spectrophotometric methods were recently reviewed by Schwedt and Dunemann (ref. 23 ) and applied to the determination of Mo in urine (80-96 ng/ml), wine (5.5-5.9 ng/ml) and plants (2.7-3.0 pg/g). Applications of other of the above methods can be found in the publication of Parker (ref. 50) 
activation analysis. They are discussed in detail below. However, it can be expected that the growing popularity of inductively coupled plasma mass spectrometry (ICP-MS), simultaneous multielement atomic absorption spectrometry (ref. 5 Another means of overcoming matrix interferences is selective thermal removal of the matrix before the atomization step. An atomization temperature of 1860 "C at which the NaCl matrix seems to have been totally volatilized was reported (ref. 64) . Complete destruction of organic compounds and selective volatilization of any matrix present were obtained by following temperature program involving drying at 100 OC, carbonization at 600 OC, charring at 1700 "C and atomization at 2700 OC (ref. 70) . This procedure, which was applied to the analysis of mineral water, also seems to be suitable for urine analysis Some matrix effects can be also corrected for by measuring the peak area and not the peak height. The peak height may vary with the matrix composition since the analyte vaporisation rate is controlled by the matrix whereas the integrated absorbance remains constant (ref. Recently, O'Haver (ref. 73 ) developed a new atomic absorption spectrometer which applies a continuum source, When coupled to a carbon furnace atomizer, it enables a multielement determination of trace elements (incl. Mo) in biological samples. Microliter samples can be used. Atomization at 2700 "C, a fast heating rate, the use of matrix modifiers such as Mg(NO,), (ref. 51) or HNO, (ref. 52 ) and efficient background correction allowed the direct Mo determination in bovine serum. However, difficulties were encountered when this method was applied to human serum because the blanks were very high and variable (3-14 ng/ml) and the detection limit (ca 2 ng/ml) was larger than the Mo level in human serum (ref. 51 ) by a factor of about 3. Although the sensitivity of this technique for Mo is still not very high and the instrument is not commercially available, its many advantages such as direct, fast multielement determination promise well for the future.
ETA AAS is the most readily available technique for the determination of Mo at the ngJg level in biological samples and recent reports (ref. 38 ,39) on its application to the determination of Mo in human serum suggest that the time has come for the introduction of ETA AAS into routine determinations of Mo in hospitals.
INDUCTIVELY COUPLED PLASMA EMISSION SPECTROMETRY (ICP AES)
Although ICP AES was widely used for the determination of many metals in biological materials in the late seventies, Mo seems to have been excluded from the multielement array of simultaneous ICP instruments. The main reasons are probably the lack of sensitivity and spectral interferences occuring in ICP AES determination of Mo. Typical detection limits quoted, 8-15 ng/ml (ref. 74, 75) are rather high in comparison with other metals and the sensitivity is often reduced even further by a dilution factor arising from sample pretreatment and/or dilution to minimize transport and nebulization effects. When determining Mo in human or bovine serum in particular but also in plants and animal tissues preliminary preconcentration of Mo is necessary in order to ensure reasonable accuracy. Background correction is important for the determination of Mo in biological materials. As the variation in background for different samples is considerable, measurements made without adequate background correction lead to incorrect results (ref. 74 ). There are two principal methods of background correction in ICP AES (the peak height and the peak area methods), each having advantages and disadvantages which should be carefully evaluated before selection. Generally, for biological samples the peak height method with its shorter measuring time, low sample consumption and moderate reproducibility is preferred to the peak area method with its longer measuring time, higher sample consumption though better precision (ref. Recently, a technique involving the use of graphite rod electrothermal vaporisation for sample introduction into an ICP discharge has been developed (ref. 81) . The use of the system allows the removal of the organic part of the matrix in the preliminary ashing step but unfortunately the major alkali and alkaline earth metal salts remain resulting in Mo signal enhancement. Separation of Mo is necessary to avoid spectral interferences. A procedure for the determination of Mo in biological samples in a multielement array has been developed but application to real sample analysis has not been reported (ref. 81) . The detection limits claimed: 70 pg (peak height method) and 160 pg (peak area method) are considerably lower than in classical ICP AES and permit the use of microvolume samples. Argon-halocarbon mixtures are required for Mo to obtain a high sensitivity but addition of a halocarbon introduces band emission similar to that observed with organic solvents. However, the electrode lifetime is long and 300-400 analyses can be performed with in situ pyrolysis. The procedures involving NAA are less susceptible to contamination as the sample dissolution and chemical separations are carried out after activation. However, although generally NAA is said to be a blank free technique, special precautions should be taken to avoid contamination during all sample pretreatment steps such as lyophilization or ashing prior to irradiation. A frequent source of error is the Mo contribution from the wall of the quartz irradiation vials. Typical blanks found for Vitrosil and Spectrosil quartz were: 1.020.6 and 0.4~0.2 ng, respectively (ref. 43) , and these are significant taking into account the Mo level in human serum, Spectrosil quartz vials, bought in large batches from the supplier are recommended. As the Mo content in polyethylene is generally lower (ref. 85) than in quartz, the use of polyethene bags is advised for the irradiation (ref. 86) .
Reactor irradiation produces the radio-isotope 99Mo (by the reaction: 98M0 (n,y) wMo) which has a halflife of 67 h and decays through p-emission to a radioactive daughter isotope %Tc with a half-life of 6 h. Instrumental NAA is based on the spectrometric measurement of the 140.5 keV photopeak of %Tc. The measurements should be carried out after at least 30 h following irradiation when equilibrium between wMo and %Tc is established and both activities decay with the parent's half life. NAA is an excellent reference technique to check on the accuracy of other methods and to establish the Mo content in CRMs. However, it is not appropriate for routine analysis as it is time consuming and requires instrumentation which is not widely available.
Recently, a new technique of instrumental NAA using epithermal neutrons for trace Mo content has been reported (ref. 53 ). Its main advantage over the classical NAA is that interfering elements are activated to a lesser extent thus rendering a post-irradiation separation unnecessary and therefore allowing a rapid instrumental determination with better accuracy. The possibility of reducing analysis time is interesting especially for busy routine hospital laboratories where it is necessary to analyse a large number of samples and to obtain accurate and reliable results. However, some technical problems arising from the necessity for neutron filters and lower neutron flux as well as high cost of the instrumentation reduce the scope of its potential applications.
CONCLUSIONS
The results of Versieck et al. (ref. 32, 33 ) obtained using techniques with a stringent contamination control are in agreement with those of other workers who claim the normal Mo serum level to be 0.5-0.6 ng/ml. However, many reports which have appeared since that time would suggest a higher value. Although the value of 0.8 ng/ml reported by Ericson et al. (ref. 38, 39 ) is within the tolerance limits, serious doubt must be placed on other considerably higher values, The probable reason for this is that some workers still analyze samples without knowing their history because it rarely hapens that the analyst himself is involved in the sample collection. It is essential to make hospital staff who are responsible for sampling aware of the stringest requirements of sample collection.
The currently accepted values of Mo levels in serum and the whole blood are similar. Does this mean that this element accumulates only in serum and not in red cells? This question remains to be elucidated.
ETA AAS and ICP AES are expected to be widely used in the near future for the routine hospital laboratory determination of Mo in urine but there remains a need for a method of appropriate sensitivity and simplicity for use in the determination of Mo in blood and serum. Supplementation of diets with trace elements is of growing popularity and AAS instruments with multi-step furnace temperature programs, Zeeman background correctors and autosamplers are required in the hospital laboratories for the monitoring required for Mo control. It must be emphasized, however, that the use of sophisticated analytical techniques will not exempt the analyst from rigorous contamination control, careful calibration and related measures required to maintain a high standard of laboratory practice. Experience and laboratory skill of the analyst are also of primary importance.
In order to improve the state of the art and to assure a good level of quality assurance CRMs for biological materials at the ng/g level are urgently needed. The issue of a CRM for human serum with ; I certified Mo content would be of enormous value. Also interlaboratory surveys of the Mo determination in human blood and serum should be undertaken.
Studies on the form of the molybdenum species in human fluids would also be of interest but with the current difficulties in the determination of total molybdenum, studies on its speciation appear to be very distant.
